FOURTH TRI SERVICE TASK FORCE MEETING 29 OCT 90

File: 102596_sep96_decls4_0004.txt
Page: 0004
Total Pages: 5

Subject: FOURTH TRI SERVICE TASK FORCE  MEETING   29 OCT 90              

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: FOURTH TRI-SERVICE TASK FORCE PROJECT BADGER                                                    

Document Number:          1

Folder SEQ  #:          4






                                                    UNCLASSIFIED


         SGRD-ZC
         SUBJECT: Fourth Tri-Service Task Force (Project Badger)
         Meeting @

         production capabilities.


             f. (U) The RFP will be prepared in parallel with the
         written market survey in order to be mailed to potential offerors
         the week of 5 November 1990.


             g. (U) Problems identified:

                 (1) Although the Army holds the patent, the Michigan
         Department of Public Health (MDPH) holds the license to anthrax
         vaccine production. While MDPH said that they are willing to
         work with us, they have also indicated their desire to approve
         any manufacturer of bulk vaccine since they are responsible for
         bottling and labelling bulk material. Insurance and
         indemnification are examples of issues that are involved.

                 (2) It was pointed out that selected companies will
         need specific information about processing, manufacturing,
         quantity and timeframe in order for them to respond meaningfully
         to the RFP.

         8. (U) Discussion then turned to botulinum toxoid.

             a. (U) MAJ Braitman reported the status of carboys. Stock
         is presently available for 20 and 40 liter carboys (encl 6).
         Availability does not appear to be a problem. The decision to
         purchase will require the finding of funds and an estimate of the
         number of carboys needed for production of the five serotypes.

             b.       Dr. Johnson-Winegar reported that Salk Institute is
         willing to@make available 3 x 200 liter holding tanks that we may
         have immediately. Replacement would be required at a cost of
         $100K each. To meet our target it appears necessary to use both
         carboys and holding tanks for production of toxoid.

             C. (U) Facilities at Pine Bluff do not have the incubators
eliminates it as a short
         term solution. Similarly, Plum Island is deleted as a short term
         solution based upon the probable inability to get FDA approval of
         botulinum toxoid for human use.

             d.       The feasibility of utilizing the U.S. Army Medical
         Research In@stitute of Infectious Diseases (USAMRIID) facilities
         was explored (encl 7). Dr. Linden was tasked to report at the
         next meeting the impact of producing all five serotypes at
         USAMRIID. She is to identify five suites at USAMRIID for vaccine
         production by 2 November 1990.   She also will identify

                                         3

                                          FunicT
                                          601       UNCLASSIFIED

Document 5 f:/Week-36/BX003202/FOURTH TRI-SERVICE TASK FORCE PROJECT BADGER/fourth tri service task force meeting 29 oct :1018961354305
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = FOURTH TRI-SERVICE TASK FORCE PROJECT BADGER
Folder Seq # = 4
Subject = FOURTH TRI SERVICE TASK FORCE MEETING 29 OCT
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996